Buy & Sell Mesoblast Limited (MESO) – Mesoblast Limited Price Today
Aura AI Summary
Key Stats
- $1.98BMarket Cap
- TechnologySector
- -13.63%3M Drawdown
- $1.99BEnterprise Value
- -Dividend Yield
- 26 daysTypical Hold Time
Mesoblast Limited (MESO) is currently valued at a market capitalization of $1.98B, with an enterprise value of $1.99B. Over the past 52 weeks, Mesoblast Limited has traded between a low of $10.16 and a high of $20.96, highlighting its annual price range. Over the past three months, Mesoblast Limited has recorded a drawdown of -13.63%, reflecting recent price volatility. On average, investors hold Mesoblast Limited for approximately 26 days, indicating typical investor behavior on the platform.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Most Recent News
Nokia executive Victoria Hanrahan buys 44,682 shares at average $15.81 in late May 2026
Victoria Hanrahan, a senior executive at Nokia, acquired a total of 44,682 Nokia shares on May 26 and May 28, 2026. The shares were purchased on the New York Stock Exchange at average prices of $16.02 and $15.60 respectively, with a combined average ...

Nokia senior manager Victoria Hanrahan acquires 44,682 shares at an average price of $15.81.
Victoria Hanrahan, a senior manager at Nokia Corporation, purchased a total of 44,682 shares on May 26 and May 28, 2026. The shares were acquired on the New York Stock Exchange at an average price of $15.81 per share. This transaction signals confide...

SCHG ETF offers low-cost growth exposure with top tech stocks like NVDA, AAPL, and MSFT, ideal for long-term investors.
The Schwab US Large-Cap Growth ETF (SCHG) provides affordable, tax-efficient access to leading growth companies, heavily weighted in technology and AI leaders such as NVIDIA, Apple, and Microsoft. These holdings benefit from strong AI adoption and ex...
